CBS 2019
CBSMD教育中心
中 文

经导管主动脉瓣置换

Abstract

Recommended Article

Outcomes of procedural complications in transfemoral transcatheter aortic valve replacement Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR Guideline Update on Indications for Transcatheter Aortic Valve Implantation Based on the 2020 American College of Cardiology/American Heart Association Guidelines for Management of Valvular Heart Disease Acute Aortic Syndrome Revisited: JACC State-of-the-Art Review Transcatheter Aortic Valve Implantation Represents an Anti-Inflammatory Therapy Via Reduction of Shear Stress–Induced, Piezo-1–Mediated Monocyte Activation Evolving concepts in the management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation 2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial

Guideline2017 Jun 20;135(25):e1159-e1195.

JOURNAL:Circulation. Article Link

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Nishimura RA, Otto CM, Bonow RO et al. Keywords: AHA Scientific Statements; anticoagulation therapy; aortic stenosis; cardiac surgery; heart valves; mitral regurgitation; prosthetic valves; transcatheter aortic valve replacement; tricuspid stenosis; valvular heart disease

FULL TEXT PDF